Trial Profile
Vildagliptin versus Standard Therapy on Coronary flow reserve in Type2 Diabetes Mellitus-Juntendo
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2015
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms VIVALDI
- 06 Jul 2015 Status changed from recruiting to completed as per University Hospital Medical Information Network - Japan record.
- 13 Jul 2012 New trial record